Picture of Geneuro SA logo

GNRO — Geneuro SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Geneuro Reports Q1 Cash Position Of 13.3 Million Euros

April 24 (Reuters) - GENEURO SA  GNRO.PA :
    * GENEURO: FINANCIAL INFORMATION AND BUSINESS UPDATE FOR THE
FIRST
QUARTER 2019
    * Q1 CASH POSITION OF €13.3 MILLION, INCLUDING €5.0 MILLION
FROM
CREDIT FACILITY
    * FINAL 12-MONTH RESULTS FROM PHASE 2A TYPE 1 DIABETES TRIAL
EXPECTED Q2 2019
    * SUCCESSFUL ANGEL-MS PHASE 2B EXTENSION STUDY RESULTS
CONFIRM AND
EXTEND NEUROPROTECTIVE EFFECTS OF TEMELIMAB IN MS
    * COMPANY RECOGNIZED €57.5K IN MANAGEMENT FEE REVENUES IN
THE
FIRST QUARTER OF 2019

Source text for Eikon:  ID:nBw80njJCa 
Further company coverage:  GNRO.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))

Recent news on Geneuro SA

See all news